Search Count: 3,438
All
Selected
 |
Organism: Streptomyces purpureus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-04-22 Classification: BIOSYNTHETIC PROTEIN Ligands: HEM, GUN, EDO, PEG, UYM, CL, MG |
 |
Cryoem Structure Of A Membrane Protein Associated With A Contractile Injection In Salmonella Enterica Subspecies Salamae
Organism: Salmonella enterica subsp. salamae
Method: ELECTRON MICROSCOPY Release Date: 2026-04-22 Classification: MEMBRANE PROTEIN |
 |
Cryo-Em Structure Of An Extracellular Contractile Injection System In Salmonella Enterica Subspecies Salamae, The Sheath And Inner Tube Module In Extended State.
Organism: Salmonella enterica subsp. salamae
Method: ELECTRON MICROSCOPY Release Date: 2026-04-22 Classification: CONTRACTILE PROTEIN |
 |
Cryo-Em Structure Of An Extracellular Contractile Injection System In Salmonella Enterica Subspecies Salamae, The Sheath In Contracted State.
Organism: Salmonella enterica subsp. salamae
Method: ELECTRON MICROSCOPY Release Date: 2026-04-22 Classification: CONTRACTILE PROTEIN |
 |
Cryo-Em Structure Of A Contractile Injection System In Salmonella Enterica Subspecies Salamae, The Cap Portion In Extended State.
Organism: Salmonella enterica subsp. salamae
Method: ELECTRON MICROSCOPY Release Date: 2026-04-22 Classification: CONTRACTILE PROTEIN |
 |
Cryo-Em Structure Of A Contractile Injection System In Salmonella Enterica Subspecies Salamae, The Baseplate Portion In Extended State.
Organism: Salmonella enterica subsp. salamae
Method: ELECTRON MICROSCOPY Release Date: 2026-04-22 Classification: CONTRACTILE PROTEIN |
 |
Erap1 In Complex With 1-[2-(6-Bromo-2,2-Difluoro-3-Oxo-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVD |
 |
Erap1 In Complex With 1-[2-(2-Oxo-5-Phenyl-2,3-Dihydro-1,3-Benzoxazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, MLT, EDO, A1JVG |
 |
Erap1 In Complex With 1-[2-(5-Chloro-2-Oxo-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVH |
 |
Erap1 In Complex With 1-[2-(3-Oxo-6-Phenyl-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVF |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Resolution:2.94 Å Release Date: 2026-04-22 Classification: MEMBRANE PROTEIN Ligands: NAG, POV, MX7, CLR, A1AT1 |
 |
Complex Of Fmdv O/18074 And Porcine-Derived Neutralizing Monoclonal Antibody Po18-10
Organism: Sus scrofa, Foot-and-mouth disease virus o
Method: ELECTRON MICROSCOPY Resolution:2.27 Å Release Date: 2026-04-22 Classification: VIRUS |
 |
Organism: Streptomyces purpureus
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-04-15 Classification: OXIDOREDUCTASE Ligands: HEM, GOL, EDO, CL, MG, NI |
 |
Organism: Human gammaherpesvirus 4
Method: ELECTRON MICROSCOPY Release Date: 2026-04-15 Classification: IMMUNE SYSTEM |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Resolution:2.77 Å Release Date: 2026-04-15 Classification: PEPTIDE BINDING PROTEIN |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Resolution:2.54 Å Release Date: 2026-04-15 Classification: PEPTIDE BINDING PROTEIN |
 |
Cryo-Em Structure Of Integrin Alpha V Beta 6 Complex With A Bicyclic Inhibitory Peptide
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2026-04-15 Classification: CELL ADHESION Ligands: CA, NAG, MAN, MN |
 |
Structure Of Chk1 10-Pt. Mutant Complex With Macrocyclic Lrrk2 Inhibitor Compound 1 ((11R)-8-Chloro-3,11-Dimethyl-2-(Oxan-4-Yl)-2,4,10,11,12,13-Hexahydro-9,5-(Azeno)Pyrazolo[3,4-B][1,4,6,10]Oxatriazacyclotridecine)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2026-04-08 Classification: TRANSFERASE/INHIBITOR Ligands: A1C5F |
 |
Structure Of Chk1 10-Pt. Mutant Complex With Macrocyclic Lrrk2 Inhibitor Compound 7 ((10As,13As)-3-Cyclobutyl-1-Methyl-8-(Trifluoromethyl)-3,4,10A,11,13A,14-Hexahydro-10H,13H-9,5-(Azeno)Furo[3,4-K]Pyrazolo[4,3-B][1,4,6,10]Oxatriazacyclotridecine)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2026-04-08 Classification: TRANSFERASE/INHIBITOR Ligands: A1C5G |
 |
Structure Of Chk1 10-Pt. Mutant Complex With Macrocyclic Lrrk2 Inhibitor Compound 12 ((10As,13As)-3-Cyclopropyl-1-Methyl-8-(Trifluoromethyl)-3,4,10A,11,13A,14-Hexahydro-10H,13H-9,5-(Azeno)Furo[3,4-K]Pyrazolo[4,3-B][1,4,6,10]Oxatriazacyclotridecine)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2026-04-08 Classification: TRANSFERASE/INHIBITOR Ligands: A1C5H |